Research group:

Demyelinating Disease

Professor Allan Kermode

MBBS, MD, FRACP, FRCP Head of Demyelinating Diseases Research

Professor Allan Kermode has worked in the Oxford University Department of Neurology and the Institute of Molecular Medicine Oxford, The National Hospital for Neurology and Neurosurgery, Queen Square, London UK, the Heidelberg Kopfklinic in Germany, and in the National Institutes of Health, USA. He has received numerous postgraduate awards and was a National Health and Medical Research Council CJ Martin Scholar. Professor Kermode has served on numerous national and international advisory boards for academia, government, and private industry. He is the former Head of Neurology at SCGH QEIIMC, and currently is Director of the Demyelinating Diseases Centre at the Perron Institute, Professor of Neurology at the University of Western Australia, Adjunct Professor of Neuroimmunology at Murdoch University, and Visiting Professor at Sun Yat-sen University, leading both clinical and fundamental research into the pathogenesis of multiple sclerosis. Professor Kermode is a member of the international disease consortia ANZGene, IMSGC, MSBase and the Progressive MS Alliance.

Professor Kermode’s scientific contributions remain the foundation for use of MRI in MS research and MS treatment trials, as well as non-invasive tissue barrier measurement in both CT and MRI, used for example in tumour treatment and gadolinium enhancement of MRI. His research has explored risk factors associated with MS, and Professor Kermode believes there are important links within this field to the long-term management of people with MS. Some of this work included large and wide-reaching collaborations with national and international experts and this important work was supported by the Wellcome Trust. Professor Kermode continues to study management strategies among the MS community, with a focus on pharmacological therapies. He has recently contributed to an expert discussion of pharmacological guideline production for MS pharmacological treatment.

View Publications Email

Publications

Liu, C., Zhao, L., Fan, P., Ko, H., Au, C., Ng, A., Au, L., Wong, A., Kermode, A.G., Mok, V., Yan, Y., Qiu, W., Lau, A.Y.
High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders (2021)
Journal of Clinical Neuroscience. 83:108-111. DOI: 10.1016/j.jocn.2020.11.016
Morgan, W.H., Khoo, Y.J., Kermode, A.G., Lind, C.R., Hazelton, M.L., Parsons, K.E., Yu, D.Y.
Utilisation of retinal vein photoplethysmography to measure intracranial pressure (2021)
Journal of Neurology, Neurosurgery and Psychiatry. 92(1):104-106. DOI: 10.1136/jnnp-2019-321072
Bukhari, W., Khalilidehkordi, E., Mason, D.F., Barnett, M.H., Taylor, B.V., Fabis-Pedrini, M., Kermode, A.G., Subramanian, S., Waters, P., Broadley, S.A., Bukhari, W., Broadley, S.A., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B.J., Brilot, F., Brownlee, W.J., Bundell, C.S., Butzkueven, H., Carroll, W.M., Chen, C., Clarke, L., Coulthard, A., Dale, R.C., Das, C., Dear, K., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A.P.D., Heshmat, S., Hodgkinson, S., Jimenez Sanchez, S., Kilpatrick, T.J., King, J., Kneebone, C., Kornberg, A.J., Lechner-Scott, J., Lin, M.-W., Lynch, C., Macdonell, R.A.L., Marriott, M.P., McCombe, P.A., O’Gorman, C., Parratt, J.D.E., Pender, M.P., Pereira, J., Pollard, J.D., Prain, K.M., Ramanathan, S., Reddell, S.W., Shaw, C., Silvestrini, R.A., Slee, M., Spies, J., Stankovich, J., Sutton, I., Vincent, A., Vucic, S., Walsh, M., Willoughby, E., Wong, R.C., Woodhall, M., Yiu, E.M.
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand (2021)
Journal of Neurology DOI: 10.1007/s00415-021-10665-9
Liu, C., Lu, Y., Wang, J., Chang, Y., Wang, Y., Chen, C., Liu, Z., Kermode, A.G., Zhang, Y., Qiu, W.
Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study (2021)
Journal of Neurochemistry DOI: 10.1111/jnc.15478
Zhong, M., van der Walt, A., Stankovich, J., Kalincik, T., Buzzard, K., Skibina, O., Boz, C., Hodgkinson, S., Slee, M., Lechner-Scott, J., Macdonell, R., Prevost, J., Kuhle, J., Laureys, G., Van Hijfte, L., Alroughani, R., Kermode, A.G., Butler, E., Barnett, M., Eichau, S., van Pesch, V., Grammond, P., McCombe, P., Karabudak, R., Duquette, P., Girard, M., Taylor, B., Yeh, W., Monif, M., Gresle, M., Butzkueven, H., Jokubaitis, V.G.
Prediction of multiple sclerosis outcomes when switching to ocrelizumab (2021)
Multiple Sclerosis Journal DOI: 10.1177/13524585211049986
Trend, S., Leffler, J., Teige, I., Frendéus, B., Kermode, A.G., French, M.A., Hart, P.H.
FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis (2021)
Frontiers in Immunology. 11 DOI: 10.3389/fimmu.2020.614492
Kalincik, T., Diouf, I., Sharmin, S., Malpas, C., Spelman, T., Horakova, D., Havrdova, E.K., Trojano, M., Izquierdo, G., Lugaresi, A., Prat, A., Girard, M., Duquette, P., Grammond, P., Jokubaitis, V., van der Walt, A., Grand'Maison, F., Sola, P., Ferraro, D., Shaygannejad, V., Alroughani, R., Hupperts, R., Terzi, M., Boz, C., Lechner-Scott, J., Pucci, E., Van Pesch, V., Granella, F., Bergamaschi, R., Spitaleri, D., Slee, M., Vucic, S., Ampapa, R., McCombe, P., Ramo-Tello, C., Prevost, J., Olascoaga, J., Cristiano, E., Barnett, M., Saladino, M.L., Sanchez-Menoyo, J.L., Hodgkinson, S., Rozsa, C., Hughes, S., Moore, F., Shaw, C., Butler, E., Skibina, O., Gray, O., Kermode, A., Csepany, T., Singhal, B., Shuey, N., Piroska, I., Taylor, B., Simo, M., Sirbu, C.-A., Sas, A., Butzkueven, H.
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years (2021)
Neurology. 96(5):e783-e797. DOI: 10.1212/WNL.0000000000011242
Li, C., Wang, J., Sun, X., Li, R., Chang, Y., Wang, Y., Zhong, X., Kermode, A.G., Mao, Z., Qiu, W.
The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China (2021)
Journal of Neuroimmunology. 353 DOI: 10.1016/j.jneuroim.2021.577506
Mishra, B., Saini, M., Doherty, C.M., Pitceathly, R.D.S., Rajan, R., Siddiqi, O.K., Ramdharry, G., Asranna, A., Tomaselli, P.J., Kermode, A.G., Bajwa, J.A., Garg, D., Vishnu, V.Y.
Use of Twitter in neurology: Boon or bane? (2021)
Journal of Medical Internet Research. 23(5) DOI: 10.2196/25229
Luo, W., Li, R., Chang, Y., She, H., Kermode, A.G., Qiu, W.
Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: Potential association between demyelination and tumor necrosis factor inhibitors (2021)
Multiple Sclerosis and Related Disorders. 51 DOI: 10.1016/j.msard.2021.102889
Luo, W., Fang, L., Wang, Z., Liu, Z., Liao, J., Meng, Z., Shen, S., Liu, B., Li, R., Kermode, A.G., Qiu, W.
Hypothalamic lesions in neuromyelitis optica spectrum disorders: exploring a scoring system based on magnetic resonance imaging (2021)
Japanese Journal of Radiology. 39(7):659-668. DOI: 10.1007/s11604-021-01104-w
Marck, C.H., Hunter, A., Heritage, B., Gibbs, L., Kermode, A.G., Walker, D.I., Learmonth, Y.C.
The effect of the Australian bushfires and the COVID-19 pandemic on health behaviours in people with multiple sclerosis (2021)
Multiple Sclerosis and Related Disorders. 53 DOI: 10.1016/j.msard.2021.103042
Clarke, L., Arnett, S., Bukhari, W., Khalilidehkordi, E., Jimenez Sanchez, S., O'Gorman, C., Sun, J., Prain, K.M., Woodhall, M., Silvestrini, R., Bundell, C.S., Abernethy, D.A., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B.J., Brownlee, W., Butzkueven, H., Carroll, W.M., Chen, C., Coulthard, A., Dale, R.C., Das, C., Fabis-Pedrini, M.J., Gillis, D., Hawke, S., Heard, R., Henderson, A.P.D., Heshmat, S., Hodgkinson, S., Kilpatrick, T.J., King, J., Kneebone, C., Kornberg, A.J., Lechner-Scott, J., Lin, M.-W., Lynch, C., Macdonell, R.A.L., Mason, D.F., McCombe, P.A., Pereira, J., Pollard, J.D., Ramanathan, S., Reddel, S.W., Shaw, C.P., Spies, J.M., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R.C., Yiu, E.M., Barnett, M.H., Kermode, A.G.K., Marriott, M.P., Parratt, J.D.E., Slee, M., Taylor, B.V., Willoughby, E., Brilot, F., Vincent, A., Waters, P., Broadley, S.A.
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis (2021)
Frontiers in Neurology. 12 DOI: 10.3389/fneur.2021.722237
Trend, S., Leffler, J., Jones, A.P., Cha, L., Gorman, S., Brown, D.A., Breit, S.N., Kermode, A.G., French, M.A., Ward, N.C., Hart, P.H.
Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis (2021)
Scientific Reports. 11(1) DOI: 10.1038/s41598-021-84881-8
Learmonth, Y.C., Chan, Z., Correia, H., Hathorn, D., Kermode, A., Smith, C., Walker, D.
Exercise participation and promotion in the multiple sclerosis community; perspectives across varying socio-ecological levels (2020)
Disability and Rehabilitation DOI: 10.1080/09638288.2020.1743778
Trend, S., Leffler, J., Cooper, M.N., Byrne, S.N., Kermode, A.G., French, M.A., Hart, P.H.
Narrowband UVB phototherapy reduces TNF production by B-cell subsets stimulated via TLR7 from individuals with early multiple sclerosis (2020)
Clinical and Translational Immunology. 9(10) DOI: 10.1002/cti2.1197
Triplett, J.D., Khor, T.S., Kermode, A.G.
Recurrent upper limb neuropathies secondary to an epithelioid haemangioendothelioma – A rare mimic of nerve tumours (2020)
Journal of Clinical Neuroscience. 73:326-328. DOI: 10.1016/j.jocn.2019.10.014
Bukhari, W., Clarke, L., O’Gorman, C., Khalilidehkordi, E., Arnett, S., Prain, K.M., Woodhall, M., Silvestrini, R., Bundell, C.S., Ramanathan, S., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B.J., Brownlee, W., Butzkueven, H., Carroll, W.M., Chen, C., Coulthard, A., Dale, R.C., Das, C., Dear, K., Fabis-Pedrini, M.J., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A.P.D., Heshmat, S., Hodgkinson, S., Jimenez-Sanchez, S., Kilpatrick, T.J., King, J., Kneebone, C., Kornberg, A.J., Lechner-Scott, J., Lin, M.-W., Lynch, C., Macdonnell, R.A.L., Mason, D.F., McCombe, P.A., Pereira, J., Pollard, J.D., Reddel, S.W., Shaw, C., Spies, J., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R.C., Yiu, E.M., Barnett, M.H., Kermode, A.G., Marriott, M.P., Parratt, J., Slee, M., Taylor, B.V., Willoughby, E., Wilson, R.J., Brilot, F., Vincent, A., Waters, P., Broadley, S.A.
The clinical profile of NMOSD in Australia and New Zealand (2020)
Journal of Neurology. 267(5):1431-1443. DOI: 10.1007/s00415-020-09716-4
Triplett, J.D., Vijayan, S., Rajanayagam, S., Tuch, P., Kermode, A.G.
Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use (2020)
Multiple Sclerosis and Related Disorders. 40 DOI: 10.1016/j.msard.2020.101961
Marsh-Wakefield, F., Ashhurst, T., Trend, S., McGuire, H.M., Juillard, P., Zinger, A., Jones, A.P., Kermode, A.G., Hawke, S., Grau, G.E., Hart, P.H., Byrne, S.N.
IgG3+ B cells are associated with the development of multiple sclerosis (2020)
Clinical and Translational Immunology. 9(5) DOI: 10.1002/cti2.1133
Chen, C., Wu, Y., Li, M., Cui, C., Zhao, Y., Sun, X., Wang, Y., Liu, C., Wu, H., Zhong, X., Kermode, A.G., Peng, L., Qiu, W.
Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders (2020)
Frontiers in Immunology. 11 DOI: 10.3389/fimmu.2020.01064
Li, R., Wang, J., Li, J., Wang, Y., Wu, H., Fan, P., Lau, A.Y., Kermode, A.G., Qiu, W.
Treatment patterns of patients with multiple sclerosis in Guangzhou, China (2020)
Neurology Asia. 25(2):173-182.
Khalilidehkordi, E., Clarke, L., Arnett, S., Bukhari, W., Jimenez Sanchez, S., O'Gorman, C., Sun, J., Prain, K.M., Woodhall, M., Silvestrini, R., Bundell, C.S., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B.J., Brown, M., Brownlee, W., Butzkueven, H., Carroll, W.M., Chen, C., Coulthard, A., Dale, R.C., Das, C., Fabis-Pedrini, M.J., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A.P.D., Heshmat, S., Hodgkinson, S., Kilpatrick, T.J., King, J., Kneebone, C., Kornberg, A.J., Lechner-Scott, J., Lin, M.-W., Lynch, C., Macdonell, R.A.L., Mason, D.F., McCombe, P.A., Pereira, J., Pollard, J.D., Ramanathan, S., Reddel, S.W., Shaw, C., Spies, J., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R.C., Yiu, E.M., Barnett, M.H., Kermode, A.G., Marriott, M.P., Parratt, J., Slee, M., Taylor, B.V., Willoughby, E., Brilot, F., Vincent, A., Waters, P., Broadley, S.A.
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation (2020)
Frontiers in Neurology. 11 DOI: 10.3389/fneur.2020.00537
Sun, X., Qiu, W., Wang, J., Wang, S., Wang, Y., Zhong, X., Liu, C., Cui, C., Hong, H., Hong, H., Yang, H., Li, X.-J., Lu, Z., Hu, X., Kermode, A.G., Kermode, A.G., Peng, L.
Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort (2020)
Journal of Neurology, Neurosurgery and Psychiatry. 91(7):733-739. DOI: 10.1136/jnnp-2019-322115
Zhou, Y., Claflin, S.B., Stankovich, J., van der Mei, I., Simpson, S., Roxburgh, R.H., Kalincik, T., Blizzard, L., Lugaresi, A., Alroughani, R., Sajedi, S.A., Butzkueven, H., Pucci, E., Spitaleri, D.L.A., Granella, F., Cristiano, E., Yamout, B., Hughes, S., Gouider, R., Sánchez Menoyo, J.L., Olascoaga, J., McGuigan, C., Shaw, C., Kermode, A.G., Kasa, K., Al-Harbi, T., Altintas, A., Laureys, G., Fragoso, Y., Hardy, T.A., Csepany, T., Sirbu, C.-A., Decoo, D., Sas, A., Alvarez-Cermeño, J.C., Kotkata, K., Millán-Pascual, J., Taylor, B.V.
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype (2020)
Multiple Sclerosis Journal. 26(13):1765-1774. DOI: 10.1177/1352458519881994
Ma, X., Kermode, A.G., Hu, X., Qiu, W.
Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy (2020)
Multiple Sclerosis and Related Disorders. 46 DOI: 10.1016/j.msard.2020.102522
Ma, X., Kermode, A.G., Hu, X., Qiu, W.
NMOSD acute attack: Understanding, treatment and innovative treatment prospect (2020)
Journal of Neuroimmunology. 348 DOI: 10.1016/j.jneuroim.2020.577387
Zhao, L., Abrigo, J., Chen, Q., Au, C., Ng, A., Fan, P., Mok, V., Qiu, W., Kermode, A.G., Lau, A.Y.
Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands (2020)
Scientific Reports. 10(1) DOI: 10.1038/s41598-020-70693-9
Zhou, Y., Jia, X., Yang, H., Chen, C., Sun, X., Peng, L., Kermode, A.G., Qiu, W.
Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes (2019)
European Journal of Neurology. 26(1):175-183. DOI: 10.1111/ene.13791
Zhong, X., Zhou, Y., Chang, Y., Wang, J., Shu, Y., Sun, X., Peng, L., Lau, A.Y., Kermode, A.G., Qiu, W.
Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of Chinese patients (2019)
Frontiers in Neurology. 10(APR) DOI: 10.3389/fneur.2019.00415
Tea, F., Lopez, J.A., Ramanathan, S., Merheb, V., Lee, F.X.Z., Zou, A., Pilli, D., Patrick, E., van der Walt, A., Monif, M., Tantsis, E.M., Yiu, E.M., Vucic, S., Henderson, A.P.D., Fok, A., Fraser, C.L., Lechner-Scott, J., Reddel, S.W., Broadley, S., Barnett, M.H., Brown, D.A., Lunemann, J.D., Dale, R.C., Brilot, F., Sinclair, A., Kermode, A.G., Kornberg, A., Bye, A., McGettigan, B., Trewin, B., Brew, B., Taylor, B., Bundell, C., Miteff, C., Troedson, C., Pridmore, C., Spooner, C., Yiannikas, C., O'Gorman, C., Clark, D., Suan, D., Jones, D., Kilfoyle, D., Gill, D., Wakefield, D., Hofmann, D., Mathey, E., O'Grady, G., Jones, H.F., Beadnall, H., Butzkueven, H., Joshi, H., Andrews, I., Sutton, I., MacIntyre, J., Sandbach, J.M., Freeman, J., King, J., O'Neill, J.H., Parratt, J., Barton, J., Garber, J., Ahmad, K., Riney, K., Buzzard, K., Kothur, K., Cantrill, L.C., Menezes, M.P., Paine, M.A., Marriot, M., Ghadiri, M., Boggild, M., Lawlor, M., Badve, M., Ryan, M., Aaqib, M., Shuey, N., Jordan, N., Urriola, N., Lawn, N., White, O., McCombe, P., Patel, R., Leventer, R., Webster, R., Smith, R., Gupta, S., Mohammad, S.S., Pillai, S., Hawke, S., Simon, S., Calvert, S., Blum, S., Malone, S., Hodgkinson, S., Nguyen, T.K., Hardy, T.A., Kalincik, T., Ware, T., Fung, V.S.C., Huynh, W.
Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination (2019)
Acta Neuropathologica Communications. 7(1) DOI: 10.1186/s40478-019-0786-3
Ghaly, S., Bliuc, D., Center, J.R., Clarke, M.W., Jones, A.P., Trend, S., Kermode, A.G., Neale, R.E., Hart, P.H.
Vitamin D C3-epimer levels are proportionally higher with oral vitamin D supplementation compared to ultraviolet irradiation of skin in mice but not humans (2019)
Journal of Steroid Biochemistry and Molecular Biology. 186:110-116. DOI: 10.1016/j.jsbmb.2018.10.002
Zhou, Y., Zhong, X., Shu, Y., Cui, C., Wang, J., Wang, Y., Li, X., Chen, Z., Peng, L., Kermode, A., Qiu, W.
Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder (2019)
Multiple Sclerosis and Related Disorders. 28:213-220. DOI: 10.1016/j.msard.2018.12.038
Shu, Y., Long, Y., Wang, S., Hu, W., Zhou, J., Xu, H., Chen, C., Ou, Y., Lu, Z., Lau, A.Y., Yu, X., Kermode, A.G., Qiu, W.
Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor (2019)
Annals of Clinical and Translational Neurology. 6(2):392-396. DOI: 10.1002/acn3.712
Joshi, S., Kermode, A.G.
Harding’s disease: An important MS mimic (2019)
BMJ Case Reports. 12(3) DOI: 10.1136/bcr-2018-228337
Triplett, J., Vijayan, S., Prince, R., Kermode, A.
Dimethyl fumarate–associated transient bone marrow oedema syndrome (2019)
Multiple Sclerosis Journal. 25(6):876-879. DOI: 10.1177/1352458518791132
Zhong, X., Chang, Y., Tan, S., Wang, J., Sun, X., Wu, A., Peng, L., Lau, A.Y., Kermode, A.G., Qiu, W.
Relapsing optic neuritis and meningoencephalitis in a child: Case report of delayed diagnosis of MOG-IgG syndrome (2019)
BMC Neurology. 19(1) DOI: 10.1186/s12883-019-1324-4
Lu, T., Zhao, L., Sun, X., Au, C., Huang, Y., Yang, Y., Bao, J., Wu, A., Kermode, A.G., Qiu, W., Lau, A.Y.
Comparison of multiple sclerosis patients with and without oligoclonal IgG bands in South China (2019)
Journal of Clinical Neuroscience. 66:51-55. DOI: 10.1016/j.jocn.2019.05.025
Triplett, J., Kermode, A.G., Corbett, A., Reddel, S.W.
Warts and all: Fingolimod and unusual HPV-associated lesions (2019)
Multiple Sclerosis Journal. 25(11):1547-1550. DOI: 10.1177/1352458518807088
Fang, L., Kang, X., Wang, Z., Wang, S., Wang, J., Zhou, Y., Chen, C., Sun, X., Yan, Y., Kermode, A.G., Peng, L., Qiu, W.
Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG (2019)
Neuroscience Bulletin. 35(5):853-866. DOI: 10.1007/s12264-019-00375-8
Trend, S., Jones, A.P., Cha, L., Cooper, M.N., Geldenhuys, S., Fabis-Pedrini, M.J., Carroll, W.M., Cole, J.M., Booth, D.R., Lucas, R.M., French, M.A., Byrne, S.N., Kermode, A.G., Hart, P.H.
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome (2019)
Scientific Reports. 9(1) DOI: 10.1038/s41598-019-44488-6
Zhong, X., Zhou, Y., Lu, T., Wang, Z., Fang, L., Peng, L., Kermode, A.G., Qiu, W.
Infections in neuromyelitis optica spectrum disorder (2018)
Journal of Clinical Neuroscience. 47:14-19. DOI: 10.1016/j.jocn.2017.10.005
Chang, Y., Shu, Y., Sun, X., Xu, C., He, D., Fang, L., Chen, C., Hu, X., Kermode, A., Qiu, W.
Ectrodactyly in a Chinese patient born to a mother with neuromyelitis optica spectrum disorder (2018)
Multiple Sclerosis and Related Disorders. 19:70-72. DOI: 10.1016/j.msard.2017.11.009
Cha, L., Jones, A.P., Trend, S., Byrne, S.N., Fabis-Pedrini, M.J., Carroll, W.M., Lucas, R.M., Cole, J.M., Booth, D.R., Kermode, A.G., Hart, P.H.
Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis (2018)
Clinical and Translational Immunology. 7(8) DOI: 10.1002/cti2.1037
Hart, P.H., Jones, A.P., Trend, S., Cha, L., Fabis-Pedrini, M.J., Cooper, M.N., d’Este, C., Geldenhuys, S., Carroll, W.M., Byrne, S.N., Booth, D.R., Cole, J.M., Lucas, R.M., Kermode, A.G.
A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study (2018)
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 4(2) DOI: 10.1177/2055217318773112
Chang, Y., Shu, Y., Sun, X., Lu, T., Chen, C., Fang, L., He, D., Xu, C., Lu, Z., Hu, X., Peng, L., Kermode, A.G., Qiu, W.
Study of the placentae of patients with neuromyelitis optica spectrum disorder (2018)
Journal of the Neurological Sciences. 387:119-123. DOI: 10.1016/j.jns.2018.01.040
Lu, T., Shu, Y., Dai, Y., Liu, X., Chang, Y., Huang, Q., Kermode, A.G., Qiu, W.
B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder (2018)
Multiple Sclerosis and Related Disorders. 22:83-85. DOI: 10.1016/j.msard.2018.03.017
Fabis-Pedrini, M.J., James, I., Seewann, A., Yau, W.Y., van de Bovenkamp, A.A., Sanders, F.R.K., Qiu, W., Burton, J., Mastaglia, F.L., Carroll, W.M., Kermode, A.G.
Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort (2018)
Journal of the Neurological Sciences. 388:12-18. DOI: 10.1016/j.jns.2018.02.036
Shu, Y., Zhang, L., Chang, Y., Li, R., Sun, X., Li, J., Wu, H., Yang, Y., Peng, L., Lu, Z., Kermode, A.G., Qiu, W.
Association of serum Cystatin C with neuromyelitis optica spectrum disorders (2018)
European Journal of Neurology. 25(7):999-1002. DOI: 10.1111/ene.13646
Lau, A., Qiu, W., Kermode, A., Au, C., Ng, A., Wong, A., Ma, S.-H., Au, L., Ma, K., Ip, B., Mok, V.
High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis (2018)
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 4(3) DOI: 10.1177/2055217318788699
Trend, S., Jones, A.P., Cha, L., Byrne, S.N., Geldenhuys, S., Fabis-Pedrini, M.J., Carroll, W.M., Cole, J.M., Booth, D.R., Lucas, R.M., Kermode, A.G., French, M.A., Hart, P.H.
Higher serum immunoglobulin G3 levels may predict the development of multiple sclerosis in individuals with clinically isolated syndrome (2018)
Frontiers in Immunology. 9(JUL) DOI: 10.3389/fimmu.2018.01590
Shu, Y., Long, Y., Chang, Y., Li, R., Sun, X., Wang, Y., Huang, Y., Li, J., Chen, J., Yang, Y., Lu, Z., Hu, X., Kermode, A.G., Qiu, W.
Brain Immunohistopathology in a Patient with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy (2018)
NeuroImmunoModulation. 25(1):1-6. DOI: 10.1159/000488879
Kalincik, T., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Lechner-Scott, J., Lugaresi, A., Prat, A., Girard, M., Duquette, P., Grammond, P., Solaro, C., Grand’Maison, F., Hupperts, R., Prevost, J., Sola, P., Ferraro, D., Terzi, M., Butler, E., Slee, M., Kermode, A., Fabis-Pedrini, M., McCombe, P., Barnett, M., Shaw, C., Hodgkinson, S., Butzkueven, H.
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis (2018)
Multiple Sclerosis Journal. 24(12):1617-1626. DOI: 10.1177/1352458517728812
Fabis-Pedrini, M.J., Bundell, C., Wee, C.-K., Lucas, M., McLean-Tooke, A., Mastaglia, F.L., Carroll, W.M., Kermode, A.G.
Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia (2018)
Journal of Neuroimmunology. 324:76-80. DOI: 10.1016/j.jneuroim.2018.09.006
Joshi, S., Yau, W., Kermode, A.
CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags (2017)
Journal of Clinical Neuroscience. 35:75-77. DOI: 10.1016/j.jocn.2016.09.025
Yau, W.Y., Fabis-Pedrini, M.J., Kermode, A.G.
Fabry heterozygote mimicking multiple sclerosis (2017)
BMJ Case Reports. 2017 DOI: 10.1136/bcr-2017-220274
Cull, G., Hall, D., Fabis-Pedrini, M.J., Carroll, W.M., Forster, L., Robins, F., Ghassemifar, R., Crosbie, C., Walters, S., James, I., Augustson, B., Kermode, A.K.
Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS (2017)
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 3(1) DOI: 10.1177/2055217317700167
Huang, Y., Wang, Y., Zhou, Y., Huang, Q., Sun, X., Chen, C., Fang, L., Long, Y., Yang, H., Wang, H., Li, C., Lu, Z., Hu, X., Kermode, A.G., Qiu, W.
Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China (2017)
Journal of the Neurological Sciences. 372:152-156. DOI: 10.1016/j.jns.2016.11.054
Hart, P.H., Lucas, R.M., Booth, D.R., Carroll, W.M., Nolan, D., Cole, J.M., Jones, A.P., Kermode, A.G.
Narrowband UVB phototherapy for clinically isolated syndrome: A trial to deliver the benefits of vitamin D and other UVB-induced molecules (2017)
Frontiers in Immunology. 8(JAN) DOI: 10.3389/fimmu.2017.00003
Jones, A.P., Kermode, A.G., Lucas, R.M., Carroll, W.M., Nolan, D., Hart, P.H.
Circulating immune cells in multiple sclerosis (2017)
Clinical and Experimental Immunology. 187(2):193-203. DOI: 10.1111/cei.12878
Stewart, T., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Prat, A., Lugaresi, A., Grand'Maison, F., Grammond, P., Sola, P., Shaygannejad, V., Hupperts, R., Alroughani, R., Oreja-Guevara, C., Pucci, E., Boz, C., Lechner-Scott, J., Bergamaschi, R., Van Pesch, V., Iuliano, G., Ramo, C., Taylor, B., Slee, M., Spitaleri, D., Granella, F., Verheul, F., McCombe, P., Hodgkinson, S., Amato, M.P., Vucic, S., Gray, O., Cristiano, E., Barnett, M., Sanchez Menoyo, J.L., Van Munster, E., Saladino, M.L., Olascoaga, J., Prevost, J., Deri, N., Shaw, C., Singhal, B., Moore, F., Rozsa, C., Shuey, N., Skibina, O., Kister, I., Petkovska-Boskova, T., Ampapa, R., Kermode, A., Butzkueven, H., Jokubaitis, V., Kalincik, T.
Contribution of different relapse phenotypes to disability in multiple sclerosis (2017)
Multiple Sclerosis. 23(2):266-276. DOI: 10.1177/1352458516643392
Fewings, N.L., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J., Booth, D.R.
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis (2017)
Journal of Autoimmunity. 78:57-69. DOI: 10.1016/j.jaut.2016.12.006
Zhou, Y., Huang, Q., Lu, T., Sun, X., Fang, L., Lu, Z., Hu, X., Kermode, A., Qiu, W.
Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG (2017)
Journal of Clinical Neuroscience. 38:71-73. DOI: 10.1016/j.jocn.2016.12.022
Fewings, N., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J., Booth, D.R.
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis (2017)
Data in Brief. 11:364-370. DOI: 10.1016/j.dib.2017.02.040
Trend, S., Jones, A.P., Geldenhuys, S., Byrne, S.N., Fabis-Pedrini, M.J., Nolan, D., Booth, D.R., Carroll, W.M., Lucas, R.M., Kermode, A.G., Hart, P.H.
Evolving identification of blood cells associated with clinically isolated syndrome: Importance of time since clinical presentation and diagnostic MRI (2017)
International Journal of Molecular Sciences. 18(6) DOI: 10.3390/ijms18061277
Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., Malhotra, S., Montalban, X., Antigüedad, A., Krupa, M., Jokubaitis, V.G., McKay, F.C., Gatt, P.N., Fabis-Pedrini, M.J., Martinelli, V., Comi, G., Lechner-Scott, J., Kermode, A.G., Slee, M., Taylor, B.V., Vandenbroeck, K., Comabella, M., Boneschi, F.M., King, C.
Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study (2017)
Pharmacogenomics Journal. 17(4):312-318. DOI: 10.1038/tpj.2016.20
Bukhari, W., Prain, K.M., Waters, P., Woodhall, M., O'Gorman, C.M., Clarke, L., Silvestrini, R.A., Bundell, C.S., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B.J., Brown, M., Brownlee, W.J., Butzkueven, H., Carroll, W.M., Chen, C., Coulthard, A., Dale, R.C., Das, C., Dear, K., Fabis-Pedrini, M.J., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A.P.D., Heshmat, S., Hodgkinson, S., Jimenez-Sanchez, S., Killpatrick, T., King, J., Kneebone, C., Kornberg, A.J., Lechner-Scott, J., Lin, M.-W., Lynch, C., Macdonell, R., Mason, D.F., McCombe, P.A., Pender, M.P., Pereira, J.A., Pollard, J.D., Reddel, S.W., Shaw, C., Spies, J., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R.C., Yiu, E.M., Barnett, M.H., Kermode, A.G., Marriott, M.P., Parratt, J.D.E., Slee, M., Taylor, B.V., Willoughby, E., Wilson, R.J., Vincent, A., Broadley, S.A.
Incidence and prevalence of NMOSD in Australia and New Zealand (2017)
Journal of Neurology, Neurosurgery and Psychiatry. 88(8):632-638. DOI: 10.1136/jnnp-2016-314839
Shu, Y., Li, R., Qiu, W., Chang, Y., Sun, X., Fang, L., Chen, C., Yang, Y., Lu, Z., Hu, X., Kermode, A.G.
Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis (2017)
Multiple Sclerosis and Related Disorders. 18:65-70. DOI: 10.1016/j.msard.2017.09.021
Li, R., Sun, X., Shu, Y., Wang, Y., Xiao, L., Wang, Z., Hu, X., Kermode, A.G., Qiu, W.
Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients (2017)
Journal of Neuroimmunology. 313:56-60. DOI: 10.1016/j.jneuroim.2017.10.013
McKay, F.C., Gatt, P.N., Fewings, N., Parnell, G.P., Schibeci, S.D., Basuki, M.A.I., Powell, J.E., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Burke, T., Vucic, S., Stewart, G.J., Booth, D.R.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies (2016)
Clinical Immunology. 163:96-107. DOI: 10.1016/j.clim.2015.12.015
Tschochner, M., Leary, S., Cooper, D., Strautins, K., Chopra, A., Clark, H., Choo, L., Dunn, D., James, I., Carroll, W.M., Kermode, A.G., Nolan, D.
Identifying patient-specific Epstein-Barr Nuclear Antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis (2016)
PLoS ONE. 11(2) DOI: 10.1371/journal.pone.0147567
Fabis-Pedrini, M.J., Xu, W., Burton, J., Carroll, W.M., Kermode, A.G.
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment (2016)
Journal of Clinical Neuroscience. 25:145-147. DOI: 10.1016/j.jocn.2015.08.027
Dai, Y., Lu, T., Wang, Y., Fang, L., Li, R., Kermode, A.G., Qiu, W.
Rapid exacerbation of neuromyelitis optica after rituximab treatment (2016)
Journal of Clinical Neuroscience. 26:168-170. DOI: 10.1016/j.jocn.2015.08.033
Yau, W.Y., Fabis-Pedrini, M.J., Kermode, A.G.
Acute reversible seronegative cerebellar ataxia in a young woman with ovarian teratoma (2016)
Journal of the Neurological Sciences. 369:227-228. DOI: 10.1016/j.jns.2016.08.033
Goris, A., Pauwels, I., Gustavsen, M.W., Van Son, B., Hilven, K., Bos, S.D., Celius, E.G., Berg-Hansen, P., Aarseth, J., Myhr, K.-M., D'Alfonso, S., Barizzone, N., Leone, M.A., Boneschi, F.M., Sorosina, M., Liberatore, G., Kockum, I., Olsson, T., Hillert, J., Alfredsson, L., Bedri, S.K., Hemmer, B., Buck, D., Berthele, A., Knier, B., Biberacher, V., Van Pesch, V., Sindi, C., Oturai, A.B., Søndergaard, H.B., Sellebjerg, F., Jensen, P.E.H., Comabella, M., Montalban, X., Pérez-Boza, J., Malhotra, S., Lechner-Scott, J., Broadley, S., Slee, M., Taylor, B., Kermode, A.G., Gourraud, P.-A., Sawcer, S.J., Andreassen, B.K., Dubois, B., Harbo, H.F.
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis (2015)
Brain. 138(3):632-643. DOI: 10.1093/brain/awu405
Pedrini, M.J.F., Seewann, A., Bennett, K.A., Wood, A.J.T., James, I., Burton, J., Marshall, B.J., Carroll, W.M., Kermode, A.G.
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females (2015)
Journal of Neurology, Neurosurgery and Psychiatry. 86(6):603-607. DOI: 10.1136/jnnp-2014-309759
Field, J., Shahijanian, F., Schibeci, S., Johnson, L., Gresle, M., Laverick, L., Parnell, G., Stewart, G., McKay, F., Kilpatrick, T., Butzkueven, H., Booth, D., Baxter, A., Kermode, A.G., Taylor, B., Booth, D.R., Mason, D., Stewart, G.J., Charlesworth, J., Wiley, J., Lechner-Scott, J., Tajouri, L., Griffiths, L., Slee, M., Brown, M.A., Moscato, P., Scott, R.J., Broadley, S., Vucic, S., Carroll, W.M.
The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: Implications for gene function (2015)
PLoS ONE. 10(6) DOI: 10.1371/journal.pone.0127080
Qiu, W., Kermode, A.G., Li, R., Dai, Y., Wang, Y., Wang, J., Zhong, X., Li, C., Lu, Z., Hu, X.
Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica (2015)
Journal of Clinical Neuroscience. 22(7):1178-1182. DOI: 10.1016/j.jocn.2015.01.028
Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J.M., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D., Willoughby, E.
A new era in the treatment of multiple sclerosis (2015)
Medical Journal of Australia. 203(3):139-141. DOI: 10.5694/mja14.01218
Gu, B.J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T.J., Lechner-Scott, J., Scott, R., Lea, R., Taylor, B.V., Stankovich, J., Butzkueven, H., Gresle, M., Laws, S.M., Petrou, S., Hoffjan, S., Akkad, D.A., Graham, C.A., Hawkins, S., Glaser, A., Bedri, S.K., Hillert, J., Matute, C., Antiguedad, A., Wiley, J.S., Baxter, A.G., Kermode, A.G., Booth, D.R., Mason, D.F., Stewart, G.J., Charlesworth, J.C., Tajouri, L., Griffiths, L.R., Slee, M., Brown, M.A., Moscato, P., Broadley, S.A., Vucic, S., Carrol, W.M., Barnett, M.H.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis (2015)
Human Molecular Genetics. 24(19):5644-5654. DOI: 10.1093/hmg/ddv278

Latest news

Keep informed with our latest updates.

View all news

Publications

High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders (2021)

Utilisation of retinal vein photoplethysmography to measure intracranial pressure (2021)

NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand (2021)

Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study (2021)

Prediction of multiple sclerosis outcomes when switching to ocrelizumab (2021)

FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis (2021)

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years (2021)

The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China (2021)

Use of Twitter in neurology: Boon or bane? (2021)

Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: Potential association between demyelination and tumor necrosis factor inhibitors (2021)

Hypothalamic lesions in neuromyelitis optica spectrum disorders: exploring a scoring system based on magnetic resonance imaging (2021)

The effect of the Australian bushfires and the COVID-19 pandemic on health behaviours in people with multiple sclerosis (2021)

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis (2021)

Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis (2021)

Exercise participation and promotion in the multiple sclerosis community; perspectives across varying socio-ecological levels (2020)

Narrowband UVB phototherapy reduces TNF production by B-cell subsets stimulated via TLR7 from individuals with early multiple sclerosis (2020)

Recurrent upper limb neuropathies secondary to an epithelioid haemangioendothelioma – A rare mimic of nerve tumours (2020)

The clinical profile of NMOSD in Australia and New Zealand (2020)

Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use (2020)

IgG3+ B cells are associated with the development of multiple sclerosis (2020)

Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders (2020)

Treatment patterns of patients with multiple sclerosis in Guangzhou, China (2020)

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation (2020)

Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort (2020)

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype (2020)

Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy (2020)

NMOSD acute attack: Understanding, treatment and innovative treatment prospect (2020)

Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands (2020)

Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes (2019)

Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of Chinese patients (2019)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination (2019)

Vitamin D C3-epimer levels are proportionally higher with oral vitamin D supplementation compared to ultraviolet irradiation of skin in mice but not humans (2019)

Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder (2019)

Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor (2019)

Harding’s disease: An important MS mimic (2019)

Dimethyl fumarate–associated transient bone marrow oedema syndrome (2019)

Relapsing optic neuritis and meningoencephalitis in a child: Case report of delayed diagnosis of MOG-IgG syndrome (2019)

Comparison of multiple sclerosis patients with and without oligoclonal IgG bands in South China (2019)

Warts and all: Fingolimod and unusual HPV-associated lesions (2019)

Myelin Oligodendrocyte Glycoprotein-IgG Contributes to Oligodendrocytopathy in the Presence of Complement, Distinct from Astrocytopathy Induced by AQP4-IgG (2019)

Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome (2019)

Infections in neuromyelitis optica spectrum disorder (2018)

Ectrodactyly in a Chinese patient born to a mother with neuromyelitis optica spectrum disorder (2018)

Tryptophan and arginine catabolic enzymes and regulatory cytokines in clinically isolated syndrome and multiple sclerosis (2018)

A randomised, controlled clinical trial of narrowband UVB phototherapy for clinically isolated syndrome: The PhoCIS study (2018)

Study of the placentae of patients with neuromyelitis optica spectrum disorder (2018)

B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder (2018)

Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort (2018)

Association of serum Cystatin C with neuromyelitis optica spectrum disorders (2018)

High prevalence and indexes of anti-John Cunningham virus antibodies in a cohort of Chinese patients with multiple sclerosis (2018)

Higher serum immunoglobulin G3 levels may predict the development of multiple sclerosis in individuals with clinically isolated syndrome (2018)

Brain Immunohistopathology in a Patient with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy (2018)

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis (2018)

Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia (2018)

CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags (2017)

Fabry heterozygote mimicking multiple sclerosis (2017)

Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS (2017)

Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China (2017)

Narrowband UVB phototherapy for clinically isolated syndrome: A trial to deliver the benefits of vitamin D and other UVB-induced molecules (2017)

Circulating immune cells in multiple sclerosis (2017)

Contribution of different relapse phenotypes to disability in multiple sclerosis (2017)

The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis (2017)

Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG (2017)

Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis (2017)

Evolving identification of blood cells associated with clinically isolated syndrome: Importance of time since clinical presentation and diagnostic MRI (2017)

Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study (2017)

Incidence and prevalence of NMOSD in Australia and New Zealand (2017)

Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis (2017)

Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients (2017)

The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies (2016)

Identifying patient-specific Epstein-Barr Nuclear Antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis (2016)

Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment (2016)

Rapid exacerbation of neuromyelitis optica after rituximab treatment (2016)

Acute reversible seronegative cerebellar ataxia in a young woman with ovarian teratoma (2016)

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis (2015)

Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females (2015)

The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: Implications for gene function (2015)

Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica (2015)

A new era in the treatment of multiple sclerosis (2015)